Abstract
Purpose
A substantial body of research indicates that self-stigma is associated with poorer outcomes related to recovery among people with severe mental illnesses. Narrative Enhancement and Cognitive Therapy (NECT) is a structured, group-based approach which targets the effects of self-stigma. A randomized-controlled trial was conducted to examine the efficacy of NECT.
Methods
One hundred and seventy persons, recruited from both outpatient and comprehensive treatment settings, meeting criteria for schizophrenia-spectrum disorders and moderate-to-elevated self-stigma, were randomly assigned to NECT or supportive group therapy and assessed at four time points over the course of nearly a year. Participants completed measures of self-stigma, hope, self-esteem, functioning, psychiatric symptoms, coping with symptoms, and narrative insight.
Results
Analyses indicated that NECT participants in outpatient sites improved significantly more over time in self-stigma compared to supportive group therapy participants in outpatient sites, while NECT participants in comprehensive (including day treatment and psychiatric rehabilitation program) sites improved significantly more in hopelessness and narrative insight than other participants. NECT participants as a group showed decreases in the social withdrawal component of self-stigma, decreased in their use of avoidant coping strategies, and were more engaged in treatment than supportive group therapy participants. There was no evidence for effects of NECT on social functioning or psychiatric symptoms.
Conclusions
Findings suggest that NECT primarily impacts self-stigma and related outcomes, and that the degree of its effects is partially dependent on the treatment context in which it is offered.
Similar content being viewed by others
References
Angermeyer MC, Dietrich S (2006) Public beliefs and attitudes toward people with mental illness: a review of population studies. Acta Psychiatr Scand 113:163–179
Pescosolido BA, Medina TR, Martin JK, Long JS (2013) The “backbone” of stigma: identifying the global core of public prejudice associated with mental illness. Am J Publ Health 103:853–860
Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M (2009) Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet 373:408–415
Brohan E, Elgie R, Sartorius N, Thornicroft G, GAMIAN-Europe Study Group (2010) Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: the GAMIAN-Europe study. Schizophr Res 122:232–238
Krajewski C, Burazeri G, Brand H (2013) Self-stigma, perceived discrimination and empowerment among people with a mental illness in six countries: pan European stigma study. Psychiatry Res 210:1136–1146
Corrigan PW, Watson AC (2002) The paradox of self-stigma and mental illness. Clin Psychol 9:35–53
West ML, Yanos PT, Smith SM, Roe D, Lysaker PH (2011) Prevalence of internalized stigma among persons with severe mental illness. Stigma Res Action 1:54–59
Livingston JD, Boyd JE (2010) Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med 71:2150–2161
Yanos PT, Roe D, Lysaker PH (2010) The impact of illness identity on recovery from severe mental illness. Am J Psychiatr Rehab 13:73–93
Yanos PT (2018) Written off: mental health stigma and the loss of human potential. Cambridge University Press, Cambridge
Beck AT, Weisman A, Lester D, Trexler L (1974) The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 42:861–865
Rosenberg M (1964) Society and the adolescent self-image. Princeton University Press, Princeton
Burns T, Patrick D (2007) Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand 116:403–418
Yanos PT, Roe D, Markus K, Lysaker PH (2008) Pathways between internalized stigma and outcomes related to recovery in schizophrenia-spectrum disorders. Psychiatr Serv 59:1437–1442
Cavelti M, Rusch N, Vauth R (2014) Is living with psychosis demoralizing? Insight, self-stigma, and clinical outcome among people with schizophrenia across 1 year. J Nerv Mental Dis 202:521–529
Yanos PT, Lucksted A, Drapalski A, Roe D, Lysaker PH (2015) Interventions targeting mental health self-stigma: a review and comparison. Psychiatr Rehab J 38:171–178
Yanos PT, Roe D, Lysaker PH (2011) Narrative enhancement and cognitive therapy: a new group-based treatment for internalized stigma among persons with severe mental illness. Int J Group Psychother 61:577–595
Yanos PT, Roe D, West ML, Smith SM, Lysaker PH (2012) Group-based treatment for internalized stigma among persons with severe mental illness: findings from a randomized controlled trial. Psychol Serv 9:248–258
Roe D, Hasson-Ohayon I, Mashiach-Eizenberg M, Derhy O, Lysaker PH, Yanos PT (2014) Narrative enhancement and cognitive therapy (NECT) effectiveness: a quasi-experimental study. J Clin Psychol 70:303–312
Hansson L, Lexen A, Holmen J (2017) The effectiveness of narrative enhancement and cognitive therapy: a randomized controlled study of a self-stigma intervention. Soc Psychiatry Psychiatr Epidemiol 52:1415–1423
Brohan E, Gauci D, Thornicroft G, for the GAMIAN–Europe Study Group (2011) Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: the GAMIAN–Europe study. J Affective Dis 129:56–63
Spitzer RL, Williams JB, Gibbon M, First M (1994) Structured clinical interview for DSM-IV. Biometrics Research, New York
Ritsher JB, Phelan JC (2004) Internalized stigma predicts erosion of morale among psychiatric outpatients. Psychiatry Res 129:257–265
Heinrichs DW, Hanlon TE, Carpenter WT (1984) The quality of life scale: an instrument for assessing the schizophrenic deficit syndrome. Schizophr Bull 10:388–396
Jaeger J, Berns SM, Czobor P (2003) The Multidimensional scale of independent functioning: a new instrument for measuring functional disability in psychiatric populations. Schizophr Bull 29:153–168
Kay S, Fiszbein A, Opler L (1987) The positive and negative syndrome scale for schizophrenia. Schizophr Bull 13:261–276
Yanos PT, Knight EL, Bremer L (2003) A new measure of coping with symptoms for use with persons diagnosed with severe mental illness. Psychiatr Rehab J 27:168–176
Lysaker PH, Taylor A, Miller A, Beattie N, Strasburger A, Davis LW (2006) The scale to assess narrative development: associations with other measures of self and readiness for recovery in schizophrenia spectrum disorders. J Nerv Ment Dis 27:233–247
Lysaker PH, Clements CA, Placak-Hallberg C, Knipschure SJ, Wright DE (2002) Insight and personal narratives of illness in schizophrenia. Psychiatry 65:197–206
Spaulding WD, Reed D, Sullivan M, Richardson C, Weiler M (1999) Effects of cognitive treatment in psychiatric rehabilitation. Schizophr Bull 25:657–676
Hayes SA, Hope DA, Terryberry-Spohr LS et al (2006) Discriminating between cognitive and supportive group therapies for chronic mental illness. J Nerv Ment Dis 194:603–609
Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis for the social, behavioral, and biomedical sciences. Beh Res Methods 39:175–191
Beck AT, Himelstein R, Bredemeier K, Silverstein SM, Grant P (2018) What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors. Psychol Med 48:2776–2785
Silverstein SM, Bellack A (2008) A scientific agenda for the concept of recovery as it applies to schizophrenia. Clin Psychol Rev 28:1108–1124
McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT (2007) A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 164:1791–1802
Silverstein SM (2010) Bridging the gap between extrinsic and instrinsic motivation in the cognitive remediation of schizophrenia. Schizophr Bull 36:949–956
Acknowledgements
This work was supported by the National Institute of Mental Health, 1R01MH0094310.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Appendix 1
Appendix 1
Rights and permissions
About this article
Cite this article
Yanos, P.T., Lysaker, P.H., Silverstein, S.M. et al. A randomized-controlled trial of treatment for self-stigma among persons diagnosed with schizophrenia-spectrum disorders. Soc Psychiatry Psychiatr Epidemiol 54, 1363–1378 (2019). https://doi.org/10.1007/s00127-019-01702-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00127-019-01702-0